Our focus is the development of highly accurate dipsticks that are extremely simple to use, read and understand.
Professor Colin Self, Founder and Chief Executive
Selective Antibodies Ltd is a UK based diagnostics company with the prime focus of overcoming key technological problems central to the production of high performance point of needs systems for small target molecules such as: medicaments, natural and unnatural toxins (such as fungal toxins and pesticides), drugs of abuse, CBRNE substances, and other substances of importance to forensic investigation, the environmental and food and water industries.
It has met this overall target by developing new technology that can be applied across the board - from high throughput analysers to very simple to use point of need applications.
The company is formed from a dynamic team of enthusiasts in the specialist areas required, from chemistry to antibody production and immunoassay design.